Liquid biopsies find distinct genomic profiles in most patients with carcinoma of unknown primary
Bottom Line: Next-generation sequencing of circulating tumor DNA (ctDNA) identified distinct genomic profiles with potentially targetable alterations in 99.7 percent ...








